BIOLOGIC AGENTS FOR PSORIASIS

Mar
2005
Vol. 24. No. 1

Introduction

Since the late 1990s, the use of biologics for psoriasis has been showcased in the dermatology literature and in educational meetings. Most of the literature has focused on the safety and efficacy data generated from clinical trials. The aim of this issue is to take this discussion one step further and examine the incorporation of these agents successfully into clinical practice.

Potential Future Therapies for Psoriasis

K Alexander Papp, MD, PhD

Much of the recent dermatology literature on new therapies has focused on large molecules, protein-based fusion proteins, and monoclonal antibodies; however, other compounds have not been neglected.

MORE